InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.005

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Change in substantial holding 26 Nov 2025 8:10PM $0.007 $0.005 fallen by 35.71%
$3 Notification regarding unquoted securities - OSX 25 Nov 2025 5:21PM $0.008 $0.005 fallen by 43.75%
$3 Cleansing Notice - Convertible Notes 25 Nov 2025 5:18PM $0.008 $0.005 fallen by 43.75%
$3 Further Drawdown of T1 of the Redeemable Convertible Notes 25 Nov 2025 5:16PM $0.008 $0.005 fallen by 43.75%
$3 OSX partners DKSH for dental products in Malaysia 25 Nov 2025 8:28AM $0.009 $0.005 fallen by 50%
$3 Becoming a substantial holder 21 Nov 2025 5:48PM $0.009 $0.005 fallen by 50%
$3 Application for quotation of securities - OSX 20 Nov 2025 7:17PM $0.009 $0.005 fallen by 50%
$3 Ceasing to be a substantial holder 10 Nov 2025 6:53PM $0.011 $0.005 fallen by 59.09%
$3 Notification of cessation of securities - OSX 4 Nov 2025 12:11PM $0.010 $0.005 fallen by 55%
$3 Activities Report September 2025 and Appendix 4C 31 Oct 2025 9:29AM $0.010 $0.005 fallen by 55%
$3 Change in substantial holding 11 Sep 2025 12:50PM $0.011 $0.005 fallen by 59.09%
$3 OSX collaborates with TTSH to develop novel implant for AVN 9 Sep 2025 8:37AM $0.012 $0.005 fallen by 60.87%
$3 Change in substantial holding 4 Sep 2025 9:09AM $0.011 $0.005 fallen by 59.09%
$3 Becoming a substantial holder 3 Sep 2025 8:38AM $0.011 $0.005 fallen by 59.09%
$3 OSX Invests AUD 0.5m in Cellular Regenerative Medicine 1 Sep 2025 8:27AM $0.012 $0.005 fallen by 62.50%
$3 OSX Invests AUD 0.5m in Cellular Regenerative Medicine 1 Sep 2025 8:27AM $0.012 $0.005 fallen by 62.50%
$3 Half Yearly Report and Accounts 29 Aug 2025 5:18PM $0.012 $0.005 fallen by 62.50%
$3 Half Yearly Report and Accounts 29 Aug 2025 5:18PM $0.012 $0.005 fallen by 62.50%
$3 Ceasing to be a substantial holder 11 Aug 2025 6:22PM $0.010 $0.005 fallen by 55%
$3 Change in substantial holding 8 Aug 2025 9:06AM $0.011 $0.005 fallen by 59.09%
$3 OSX & Universiti Malaya initiate dental bone healing trial 8 Aug 2025 9:00AM $0.011 $0.005 fallen by 59.09%
$3 Change in substantial holding 6 Aug 2025 6:08PM $0.011 $0.005 fallen by 59.09%
$3 OSX ortho product successful in Vietnam hospital tender bids 4 Aug 2025 8:57AM $0.012 $0.005 fallen by 62.50%
$3 Change in substantial holding 31 Jul 2025 6:34PM $0.011 $0.005 fallen by 59.09%
$3 Application for quotation of securities - OSX 31 Jul 2025 6:25PM $0.011 $0.005 fallen by 59.09%

101 - 125 of 515 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.